PARIS – Sanofi (NASDAQ: SNY) agreed on terms to sell a controlling stake in its consumer health unit Opella to
1 year ago
PARIS – On Monday, Sanofi (NASDAQ: SNY), the French drugmaker, said it had entered exclusive talks to sell a 50%
NEW YORK – On Thursday, U.S. consumer groups and two large labor unions urged the U.S. Federal Trade Commission to
The U.S. Food and Drug Administration has put on hold a trial of Novavax’s (NASDAQ: NVAX) COVID-influenza and its standalone
GlaxoSmithKline (NYSE: GSK), the British drugmaker, sued Moderna (NASDAQ: MRNA) in U.S. federal court in Delaware on Tuesday, accusing it
LONDON – Britain will study whether the use of Eli Lilly’s (NYSE: LLY) weight loss drug can get people back
UnitedHealth Group (NYSE: UNH) provided a 2025 profit forecast below Wall Street estimates on Tuesday as it expects pressure across
Johnson & Johnson (NYSE: JNJ) raised its 2024 profit and sales forecasts on Tuesday after reporting strong sales of oncology
On Monday, Vanda Pharmaceuticals (NASDAQ: VNDA) rejected UK-based Cycle Pharmaceuticals’ second takeover proposal, which values the drugmaker at $8 per
PARIS – The French government needs guarantees from drugmaker Sanofi (NASDAQ: SNY) that production of its popular Doliprane painkiller will
Catalent (NYSE: CTLT) has agreed to sell its oral drug development and small-scale manufacturing facility in Somerset, New Jersey to
H Lundbeck A/S has agreed to buy Longboard Pharmaceuticals (NASDAQ: LBPH) for $2.6 billion, marking the biggest deal ever by
